Entero Healthcare Solutions Limited has informed the Exchange about Amalgamation/Merger
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Regional Director, Southern Region, Chennai, Ministry of Corporate Affairs, confirmed the Scheme of Amalgamation under Section 233 of the Companies Act, 2013. The scheme involves merger of two wholly-owned subsidiaries - Chethana Pharma Distributors Private Limited and CPD Pharma Private Limited - into Rada Medisolutions Private Limited (Transferee Company). The appointed date was April 15, 2025, and the confirmation order was received on May 5, 2026. Both transferor companies are engaged in pharmaceutical distribution and marketing. Since both are wholly owned subsidiaries, no new shares will be issued and investments will be cancelled. Post-merger, the authorized share capital of the Transferee Company increases to Rs. 1,35,00,000.
The direct impact on Entero Healthcare Solutions is minimal as this involves internal subsidiary restructuring. The merger may lead to operational efficiencies and cost savings in the pharma distribution business under Rada Medisolutions over time.